Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong · Delayed Price · Currency is HKD 474.40
-6.60 (-1.37%)
Sep 10, 2026, 4:08 PM HKT
HKG:6990 Market Cap
HKG:6990 has a market cap or net worth of 113.39 billion as of September 10, 2026. Its market cap has decreased by -5.22% in one year.
Market Cap
113.39B
Enterprise Value
107.97B
Revenue
2.41B
Ranking
n/a
PE Ratio
649.56
Stock Price
474.40
ChartMarket Cap Chart
Since July 11, 2023, HKG:6990's market cap has increased from 13.49B to 113.39B, an increase of 740.61%. That is a compound annual growth rate of 95.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 113.39B | 23.99% |
| Dec 31, 2025 | 91.46B | 146.43% |
| Dec 31, 2024 | 37.11B | 64.54% |
| Dec 29, 2023 | 22.56B | 67.21% |
| Jul 11, 2023 | 13.49B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 312.97B |
| WuXi Biologics | 200.43B |
| Innovent Biologics | 170.96B |
| Sino Biopharmaceutical | 99.91B |
| Akeso | 87.55B |
| Genscript Biotech | 73.65B |
| RemeGen | 63.20B |
| Biocytogen Pharmaceuticals (Beijing) | 56.25B |